Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Parasomnias 2Lung Neoplasms 2Weight Loss 1Uveal Melanoma 1Tuberous Sclerosis 1Squamous Cell Carcinoma of Head and Neck 1Smith-Magenis Syndrome 1Sleep Wake Disorders 1Neoplasms 1Gastrointestinal Neoplasms 1Carcinoma, Non-Small-Cell Lung 1Cachexia 1Breast Cancer - Female 1Barrett Esophagus 1Autism Spectrum Disorder 1Anorexia 1Angelman Syndrome 1

Interventions

X-Rays 1Omeprazole 1Melatonin 1Esomeprazole 1Endoscopy, Digestive System 1Endoscopy 1Blood Specimen Collection 1Biopsy 1Aspirin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 3 × Barrett Esophagus × Melatonin × Clear all
NCT01566474 2019-09-13

Melatonin Associated to Acid Inhibition for Chemoprevention in Barret Esophagus: a Pilot Study

Aragon Institute of Health Sciences

Phase 3 Completed
80 enrolled
Gastrointestinal

Barrett Esophagus

Data powered by HemOnc (CC BY 4.0) Colophon âš¡